Copyright
©The Author(s) 2024.
World J Gastroenterol. Aug 7, 2024; 30(29): 3511-3533
Published online Aug 7, 2024. doi: 10.3748/wjg.v30.i29.3511
Published online Aug 7, 2024. doi: 10.3748/wjg.v30.i29.3511
Figure 5 Calculus bovis-enriched serum inhibits polarization of M2 tumor-associated macrophages.
A: Cytotoxicity of Calculus bovis-enriched serum (CBS) on THP-1 cells by Cell Counting Kit-8 assay. The blank group served as a control; B: CD206 quantification in THP-1 cells after IL-4 and IL-13 induction by flow cytometry; C: The mRNA expression levels of CD206 after intervention of M2 tumor-associated macrophages (M2-TAMs) with different concentrations of blank serum and CBS; D: Quantification of CD206 in M2-TAMs after 10% (100 mL/L) CBS intervention by flow cytometry; E: The mRNA expression levels of CCL22, TGF-β2, IL-10, and Arg-1 after 10% (100 mL/L) CBS intervention in M2-TAMs. dP < 0.05, eP < 0.01. BS: Blank serum; CBS: CB-enriched serum.
- Citation: Huang Z, Meng FY, Lu LZ, Guo QQ, Lv CJ, Tan NH, Deng Z, Chen JY, Zhang ZS, Zou B, Long HP, Zhou Q, Tian S, Mei S, Tian XF. Calculus bovis inhibits M2 tumor-associated macrophage polarization via Wnt/β-catenin pathway modulation to suppress liver cancer. World J Gastroenterol 2024; 30(29): 3511-3533
- URL: https://www.wjgnet.com/1007-9327/full/v30/i29/3511.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i29.3511